(lp0
S'How Does Anthera Pharmaceuticals, Inc.  Stack Up Right Now? StockNewsJournal - 13 hours ago Anthera Pharmaceuticals, Inc.  is an interesting player in the Healthcare space, with a focus on Biotechnology.Anthera Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 20 - Equities.comAnthera Pharmaceuticals, Inc.  has Current Market Capitalizaion of $34.9 ... - The Newburgh Press'
p1
aS'Anthera Pharmaceuticals Inc.  Settles Into New 52-Week Low on March 22 ... Equities.com - 8 hours ago Shares of Anthera Pharmaceuticals Inc.  sank into a new 52-week low yesterday, and could be a company to watch at the open.'
p2
aS'ANTHERA PHARMACEUTICALS, INC.  Files An 8-K Results of Operations ... Market Exclusive - Feb 27, 2017 Anthera Pharmaceuticals, Inc.  is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including enzyme replacement therapies and autoimmune diseases.Research Reports Coverage on Biotech Stocks -- Anthera Pharma, Arrowhead ... - PR Newswire '
p3
aS'Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock and ... GlobeNewswire  - Mar 13, 2017 HAYWARD, Calif., March 13, 2017  -- Anthera Pharmaceuticals, Inc.   today announced that it intends to offer and sell shares of its common stock and warrants to purchase shares of its common stock in an&nbsp;...'
p4
aS'Anthera Pharmaceuticals Inc : Ignore The Lawsuits Insider Financial - Feb 23, 2017 Levi &amp; Korsinsky, Lifshitz &amp; Miller, Bronstein, Gewirtz &amp; Grossman, Johnson &amp; Weaver - just some of the LLPs flooding the PR streams for Anthera Pharmaceuticals Inc  at the major financial news outlets. Every one of these companies claims&nbsp;...Anthera Pharmaceuticals Inc.  Soars 11.14% on February 22 - Equities.com'
p5
aS'IMPORTANT ANTHERA PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler ... GlobeNewswire  - Feb 24, 2017 INVESTOR ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of purchasers of Anthera Pharmaceuticals, Inc.'
p6
aS'Anthera Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 16 Equities.com - Mar 16, 2017 Anthera Pharmaceuticals Inc.  traded on unusually high volume on Mar. 16, as the stock gained 1.43% to close at $0.41.ANTHERA PHARMACEUTICALS,INC.  Files An 8-K Entry into a Material ... - Market ExclusiveStock Showing Surging Activity: Anthera Pharmaceuticals, Inc.  - HugoPress'
p7
aS'Anthera Pharmaceuticals Inc.  Plunges 8.39% on March 03 Equities.com - Mar 3, 2017 Anthera Pharmaceuticals Inc.  had a rough trading day for Friday March 03 as shares tumbled 8.39%, or a loss of $-0.0586 per share, to close at $0.64.Featured Stock to Focus: Synergy Pharmaceuticals, Inc.  - HugoPress'
p8
aS'Anthera Pharmaceuticals Inc.  Plunges 5.29% on March 02 Equities.com - Mar 2, 2017 Anthera Pharmaceuticals Inc.  had a rough trading day for Thursday March 02 as shares tumbled 5.29%, or a loss of $-0.039 per share, to close at $0.70.Anthera Pharmaceuticals, Inc.  Insider Ownership stands at 0.1 - The Newburgh PressAnalyst Hints Surrounding Anthera Pharmaceuticals, Inc.  - Post Analyst'
p9
aS"Anthera Pharmaceuticals, Inc.  hit its 52 Week high of $4.41 on Apr 22, 2016 The Newburgh Press - 17 hours ago Considering the performance, Anthera Pharmaceuticals, Inc. 's shares have the potential to reach a high EPS of -0.17 per share, and a low EPS of -0.36 per share in the current quarter."
p10
a.